ConductScience.org, home

Paper39225830

Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.

Ashayeri Ahmadabad H and 5 others. Naunyn Schmiedebergs Arch Pharmacol, 2025. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases. Papers, record 39225830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39225830

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
5.66, provisional
iCite
Revised in PubMed
2026-11-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ashayeri Ahmadabad HHemin
2Mohammadi Panah SSomayeh
3Ghasemnejad-Berenji HHojat
4Ghojavand SShabnam
5Ghasemnejad-Berenji MMortezahttps://orcid.org/0000-0001-5672-9202
6Khezri MRMohammad Rafihttps://orcid.org/0000-0002-4280-0378

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MetforminMajor topic
Proto-Oncogene Proteins c-aktMajor topic
NeoplasmsMajor topic
Cardiovascular DiseasesMajor topic
Phosphatidylinositol 3-KinasesMajor topic
Central Nervous System DiseasesMajor topic
Hypoglycemic AgentsMajor topic
Humans
Signal Transduction
Animals

Source PubMed

Download CSV of topics

References142

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117054901Dynamic phospholipid signaling by G protein-coupled receptors.Biochim Biophys Acta2007https://conductscience.org/library/papers/17054901PubMed
231611073Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease.Adv Biol Regul2020https://conductscience.org/library/papers/31611073PubMed
335118422The present and future of PI3K inhibitors for cancer therapy.Nat Cancer2021https://conductscience.org/library/papers/35118422PubMed
410329640Insulin activates the alpha isoform of class II phosphoinositide 3-kinase.J Biol Chem1999https://conductscience.org/library/papers/10329640PubMed
519143635A complex interplay between Akt, TSC2 and the two mTOR complexes.Biochem Soc Trans2009https://conductscience.org/library/papers/19143635PubMed
630849534The relation between PI3K/AKT signalling pathway and cancer.Gene2019https://conductscience.org/library/papers/30849534PubMed
731161345Type 2 diabetes: a multifaceted disease.Diabetologia2019https://conductscience.org/library/papers/31161345PubMed
828527533Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.J Am Coll Cardiol2017https://conductscience.org/library/papers/28527533PubMed
921277873Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.Neuropharmacology2011https://conductscience.org/library/papers/21277873PubMed
1024519956Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.Oncotarget2014https://conductscience.org/library/papers/24519956PubMed
119609111Insulin regulation of the Ras activation/inactivation cycle.Mol Cell Biochem1998https://conductscience.org/library/papers/9609111PubMed
1219622833Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.Sci Signal2009https://conductscience.org/library/papers/19622833PubMed
1334298660Akt Isoforms: A Family Affair in Breast Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34298660PubMed
1431275108Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway.Front Neurosci2019https://conductscience.org/library/papers/31275108PubMed
1532792857Metformin suppresses inflammation and apoptosis of myocardiocytes by inhibiting autophagy in a model of ischemia-reperfusion injury.Int J Biol Sci2020https://conductscience.org/library/papers/32792857PubMed
1629678660Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.Gene2018https://conductscience.org/library/papers/29678660PubMed
1733450488Curcumin and cardiovascular diseases: Focus on cellular targets and cascades.Biomed Pharmacother2021https://conductscience.org/library/papers/33450488PubMed
1834283253Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice.Exp Brain Res2021https://conductscience.org/library/papers/34283253PubMed
1920563706Role of RAS in the regulation of PI 3-kinase.Curr Top Microbiol Immunol2010https://conductscience.org/library/papers/20563706PubMed
2031170502The beneficial roles of metformin on the brain with cerebral ischaemia/reperfusion injury.Pharmacol Res2019https://conductscience.org/library/papers/31170502PubMed

See all 142 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42904151Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review.Cancer Manag Res2026https://conductscience.org/library/papers/42904151PubMed
42737460Functional Characterization of Putative Novel MicroRNA-1133 in the Antioxidant Effects of Metformin in Hyperglycemia-Induced Endothelial Cells.Int J Mol Sci2026https://conductscience.org/library/papers/42737460PubMed
42656432Exploring the relationship between uric acid-to-HDL cholesterol ratio and vascular calcification: evidence from clinical, genetic, and network-based analyses.Front Cardiovasc Med2026https://conductscience.org/library/papers/42656432PubMed
42439660Deciphering the Anti-Tumor Mechanisms of Metformin Through Reprogramming of the Tumor Microenvironment.Cells2026https://conductscience.org/library/papers/42439660PubMed
42136854Mechanisms of interaction between type 2 diabetes and psychological disorders and therapeutic interventions: a narrative review.Front Med (Lausanne)2026https://conductscience.org/library/papers/42136854PubMed
41704279Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies.Front Pharmacol2026https://conductscience.org/library/papers/41704279PubMed
41562920Integrative Sequencing and Proteogenomic Approaches to Intratumoral Heterogeneity in Cholangiocarcinoma: Implications for Precision Diagnosis and Therapy.Med Sci (Basel)2026https://conductscience.org/library/papers/41562920PubMed
41382186Enhancing PARP inhibitor efficacy in ovarian cancer: targeting the PI3K/AKT/mTOR pathway.J Ovarian Res2025https://conductscience.org/library/papers/41382186PubMed
41373567Antitumor Activity of Metformin in Combination with Binimetinib Against Melanoma Cells.Int J Mol Sci2025https://conductscience.org/library/papers/41373567PubMed
41366593Therapeutic Efficacy of Autologous Blood-Derived Stem Cells with Growth Factors in Moderate to Severe Alzheimer's Disease: A Clinical Trial.Mol Neurobiol2025https://conductscience.org/library/papers/41366593PubMed
41185504Aloperine Protects Against Cisplatin-Induced Injury in Kidney Cells Via Modulating PI3K/AKT/Nfκb-Mediated NLRP3 Inflammasome.Protein Pept Lett2025https://conductscience.org/library/papers/41185504PubMed
41082699Hesperidin and Hesperetin from Orange Peel Water Extract Protect against NaIO3-Induced Oxidative Damage in Retinal Pigment Epithelial Cells by Modulating PI3K/Akt/HIF-1α/BNIP3 Signaling.J Agric Food Chem2025https://conductscience.org/library/papers/41082699PubMed
40916522[Exosome-derived miR-1275 mediates IL-38 upregulation in lymphocytes to suppress lipopolysaccharide-induced apoptosis of myocardial cells in vitro].Nan Fang Yi Ke Da Xue Xue Bao2025https://conductscience.org/library/papers/40916522PubMed
40805165Metformin Beyond Diabetes: A Precision Gerotherapeutic and Immunometabolic Adjuvant for Aging and Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/40805165PubMed
40385486Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease.Front Pharmacol2025https://conductscience.org/library/papers/40385486PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39225830

GET https://conductscience.org/api/papers/v1/39225830/references?page=2